REAGILA (Gedeon Richter Australia Pty Ltd)
Product name
REAGILA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
196 working days (255)
Active ingredients
cariprazine hydrochloride
Registration type
NCE/NBE
Indication
REAGILA (hard capsule) is indicated for the treatment of schizophrenia in adult patients.